Rozlytrek in ROS1+ & NTRK+ NSCLC | Targeted Therapy for Fusion-Driven Lung Cancer
10:35
Rozlytrek in ROS1+ & NTRK+ NSCLC | Targeted Therapy for Fusion-Driven Lung Cancer
55 views10 months ago
YouTubeCancer Research and Statistic Foundation
Dr. Patel on the Safety Profile of Entrectinib in NTRK+ Solid Tumors
1:25
Dr. Patel on the Safety Profile of Entrectinib in NTRK+ Solid Tumors
125 viewsAug 31, 2020
YouTubeOncLive
Dr. Cohen Discusses Entrectinib in Head and Neck Cancer
2:08
Dr. Cohen Discusses Entrectinib in Head and Neck Cancer
157 viewsOct 25, 2017
YouTubeOncLive
Entrectinib–Selective ROS Inhibition
4:45
Find in video from 00:25Safety Signals of Entrectinib vs Lera Tractin
Entrectinib–Selective ROS Inhibition
349 viewsAug 12, 2019
YouTubeTargeted Oncology
Treatment for NTRK+ NSCLC: Larotrectinib & Entrectinib - 2022 Program: Targeted Therapies Forum
8:54
Treatment for NTRK+ NSCLC: Larotrectinib & Entrectinib - 2022 Program: Targeted Therapies Forum
80 viewsDec 7, 2022
YouTubeGlobal Resource for Advancing Cancer Education
Entrectinib in NTRK-fusion positive gastrointestinal cancers
3:54
Entrectinib in NTRK-fusion positive gastrointestinal cancers
92 viewsJul 15, 2019
YouTubeecancer
Analyzing the Data for Entrectinib in ROS1 TKI-Naive Patients With NSCLC
1:22
Analyzing the Data for Entrectinib in ROS1 TKI-Naive Patients With NSCLC
245 viewsJun 5, 2019
YouTubeTargeted Oncology
Entrectinib: A Review in NTRK Solid Tumours and ROS1 NSCLC - Drugs
Apr 1, 2021
springer.com
9:34
Safety analysis of entrectinib for NTRK fusion tumours
591 viewsOct 29, 2018
YouTubeecancer
10:50
ALKA-372-001, STARTRK-1, and STARTRK-2 Trials
152 viewsSep 14, 2020
YouTubeOncLive
20:04
AskSam 11 28 22 Part 2
2.1K viewsDec 23, 2022
YouTubeValAsta
11:30
Latest Advances in Tumor-Agnostic Strategies for NTRK Fusion-Positive Cancer
2.7K views9 months ago
YouTubeOncBrothers: Practice-Changing Cancer Discu…
1:30
Evaluating the FDA Approval of taletrectinib for ROS+ NSCLC
68 views8 months ago
YouTubeVJOncology
1:24
【赴宜康】恩曲替尼(Entrectinib)说明书介绍，治疗效果和副作用，用法用量
129 views2 months ago
bilibili赴宜康医药查询
Choosing Larotrectinib vs Entrectinib to Treat NTRK Fusion Lung Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Sep 4, 2022
targetedonc.com
16:12
Managing Toxicities of ROS1 Inhibitors in Non-Small Cell Lung Cancer (NSCLC) – Dr. Estela Rodriguez
5K views5 months ago
YouTubeOncBrothers: Practice-Changing Cancer Discu…
3:17
FDA Approval of Taletrectinib for ROS1+ NSCLC: Dr. Liu Weighs In
221 views10 months ago
YouTubeLung Cancers Today
2:57
Key Points about ROS1-Positive Lung Cancer
2.6K viewsJan 6, 2021
YouTubeAmerican Lung Association
5:14
Targeted Therapy in Non-Small Cell Lung Cancer - updated 2025
1.6K views8 months ago
YouTubeYou and Lung Cancer
2:39
Dr Lin on the Efficacy and Safety of Taletrectinib in ROS1 Fusion+ NSCLC
586 viewsJul 4, 2024
YouTubeOncLive
34:53
The Power of Personalised Approaches in Advanced CCA
147 views5 months ago
YouTubePeerView Oncology
1:56
ROS1-Positive Lung Cancer and Brain Tumors
1.3K viewsJan 6, 2021
YouTubeAmerican Lung Association
2:17
Long term safety of targeted therapies
3.9K viewsFeb 2, 2024
YouTubeSpringer Health+ IME
5:53
Targeted Therapy in Non-Small Cell Lung Cancer
56.2K viewsMay 21, 2021
YouTubeYou and Lung Cancer
40:08
Unlocking the Secrets of Individualised Management of Resectable EGFRm NSCLC
5 views3 weeks ago
YouTubePeerView Oncology
1:30
What are NTRK Gene Fusions?
2.8K viewsNov 2, 2020
YouTubeAmerican Lung Association
4:55
Taletrectinib shows efficacy and tolerability in advanced ROS1+ NSCLC previously treated with en...
25 views3 months ago
YouTubeecancer
2:57
Dr Mok on the Efficacy of Taletrectinib in ROS1+ NSCLC
273 viewsOct 25, 2024
YouTubeOncLive
4:18
Made in Italy terapia intelligente contro raro tumore del polmone e altre neoplasie solide
157 viewsSep 15, 2021
YouTubeAdnkronos
1:27
Targeted Therapies Show Activity in ROS1 Fusion-Positive Lung Cancer
701 viewsMar 18, 2020
YouTubeTargeted Oncology
See more